Search

everythinglearnresearchcommunity

for

Search:↓

A man had temporary hair loss after a spinal cord injury, with some permanent thinning remaining.

Treating hyperprolactinemia can help manage PCOS symptoms.

Androgenetic alopecia, or common baldness, is the main cause of hair loss in men due to shrinking hair follicles from hormones, and it's normal but can be a problem if it's too much or too early.

Alopecia significantly lowers women's quality of life, with psychological and social challenges, highlighting the importance of early treatment and support.

More people, especially Hispanic/Latinx, in certain NYC communities experienced temporary hair loss during the COVID-19 pandemic.

The 2004 hair research meeting presented new findings on hair cell differentiation, genetic factors in hair loss, hair pigmentation, and potential targeted therapies.

Finasteride improves urinary symptoms and quality of life in BPH patients, especially with larger prostate size.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

CLASI is a valid tool for assessing skin activity and damage in lupus patients.

The data suggests that dosing differences can help manage spasticity in patients with upper motor neuron dysfunction.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Black women's unique hair characteristics and styling practices can lead to specific scalp conditions, which require early diagnosis and appropriate treatment.

Patients with multiple superficial venous thrombosis are at greater risk for serious complications like cancer and recurrent blood clots.

Patients using social media have mixed feelings about alopecia treatments, noting hair growth but also frustration with treatment recurrence.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

A patient with total hair loss developed vitiligo after using a treatment called DCP.

Chemotherapy patients don't all lose their hair due to factors like hair growth rates, age, genetics, and the type of drugs used.

Higher disease activity in systemic lupus erythematosus is strongly linked to more internal organ damage.

Tjalma Syndrome is a rare condition in people with lupus, causing fluid buildup and high CA-125 levels, but not due to tumors.

The patient's hair loss is most likely due to diffuse alopecia areata.

Diabetic patients often have ingrown nails due to obesity, high blood pressure, past injuries, bad nail trimming, nail fungus, weak foot pulse, and weak knee reflex.

Many patients with Alopecia Areata in Korea experience anxiety, depression, and reduced quality of life, which are often unrelated to the severity of hair loss.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

A patient with untreated congenital adrenal hyperplasia had large benign tumors in her adrenal glands removed, improving her symptoms.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Patients with mycosis fungoides have a higher risk of heart disease.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Alzheimer's patients have higher levels of certain chemicals in their hair.

The article concludes that it's important to know how to identify and treat the rare hair disease black piedra, even in places where it's not usually found.

Minoxidil treats hair loss, promotes growth, has side effects, and has recent patents.